Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Aging is one of the most important risk factors for the development of several neurodegenerative diseases including progressive multiple sclerosis (MS). Cellular senescence (CS) is a key biological process underlying aging. Several stressors associated with aging and MS pathology, such as oxidative stress, mitochondrial dysfunction, cytokines and replicative exhaustion are known triggers of cellular senescence. Senescent cells exhibit stereotypical metabolic and functional changes, which include cell-cycle arrest and acquiring a pro-inflammatory phenotype secreting cytokines, growth factors, metalloproteinases and reactive oxygen species. They accumulate with aging and can convert neighboring cells to senescence in a paracrine manner. In MS, accelerated cellular senescence may drive disease progression by promoting chronic non-remitting inflammation, loss or altered immune, glial and neuronal function, failure of remyelination, impaired blood-brain barrier integrity and ultimately neurodegeneration. Here we discuss the evidence linking cellular senescence to the pathogenesis of MS and the putative role of senolytic and senomorphic agents as neuroprotective therapies in tackling disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“Cellular senescence (CS) has been recognized as a key biological process underling normal aging (López-Otín et al., 2013; Gorgoulis et al., 2019) and evidence suggest that the accumulation of senescent cells with time may contribute to the pathogenesis of age-related and neurodegenerative disease (Kritsilis et al.”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Lifelong elimination of p16INK4A cells in BubR1 progeroid mice by activation of an INK-ATTAC transgene substantially delayed age-related disease, whereas late life elimination of p16INK4A cells attenuated these age-related pathologies (Baker et al., 2011).”
BackgroundAgeing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 1×
“Aging is the most important risk factor for the development of neurodegenerative disease (Hou et al., 2019).”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence (CS) has been recognized as a key biological process underling normal aging (López-Otín et al., 2013; Gorgoulis et al., 2019) and evidence suggest that the accumulation of senescent cells with time may contribute to the pathogenesis of age-related and neurodegenerative disease (Kritsilis et al.”
BackgroundSelf-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
Ming, G.-L., & Song, H. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.001 · Cited by 2,651 · cited 1×
“They are thought to primarily reside in the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus (Kriegstein and Alvarez-Buylla, 2009; Ming and Song, 2011).”
BackgroundThe Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475 · cited 1×
“They are thought to primarily reside in the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus (Kriegstein and Alvarez-Buylla, 2009; Ming and Song, 2011).”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 2×
“These are capable of affecting neighboring cells and converting them to senescence in a paracrine manner (Kuilman and Peeper, 2009; Acosta et al., 2013).”
BackgroundResultFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 3×
“The number of senescent cells increases with age (Rodier and Campisi, 2011).”
BackgroundMultiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 1×
“In addition, a senolytic compound (ABT263) was shown to attenuate tau phosphorylation and aggregation and to improve memory deficits in the PS19 transgenic model of tau-dependent neurodegeneration, by removing senescent glial cells (Bussian et al., 2018).”
BackgroundThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · cited 7×
“Cell cycle arrest of adult progenitor cells in the context of CS or inhibitory paracrine stimuli by neighboring senescent cells may impair progenitor proliferation, reduce the regenerative capacities of the CNS and render it susceptible to neurodegeneration.”
BackgroundInfluentialProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977
Origin of oligodendrocytes in the subventricular zone of the adult brain
Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1299-06.2006 · Cited by 972 · cited 1×
“In addition, studies have demonstrated that adult NPCs from the subventricular zone (SVZ) and the spinal cord contribute to the generation of new oligodendrocytes and myelin repair in models of demyelination (Nait-Oumesmar et al., 1999; Danilov et al., 2006; Menn et al., 2006; Xing et al., 2014; Maeda et al., 2019).”
BackgroundSenescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909 · cited 1×
“These are capable of affecting neighboring cells and converting them to senescence in a paracrine manner (Kuilman and Peeper, 2009; Acosta et al., 2013).”
BackgroundBlood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · cited 1×
“Age-related accumulation of senescent endothelial cells is linked to impaired tight junction structure and compromised blood-brain barrier (BBB) function (Farrall and Wardlaw, 2009; Yamazaki et al., 2016; Castellazzi et al., 2020).”
BackgroundMitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796
Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks
Sedelnikova, O. A., Horikawa, I., Zimonjic, D. B., Popescu, N. C., Bonner, W. M., & Barrett, J. C. (2004) · Nature Cell Biology · doi:10.1038/ncb1095 · Cited by 790 · cited 2×
“Neurons of aged mice have been shown to accumulate hallmarks of cellular senescence including doublestrand DNA breaks, heterochromatinization, upregulation of SAβ- Gal, p38MAPK activation and production of SASP-related mediators including ROS and IL-6 (Sedelnikova et al., 2004; Jurk et al., 2012).”
BackgroundMyelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727
Dystrophic microglia in the aging human brain
Streit, W. J., Sammons, N. W., Kuhns, A. J., & Sparks, D. L. (2004) · Glia · doi:10.1002/glia.10319 · Cited by 705 · cited 2×
“Evidence supports the functional significance of NPCs as hippocampal neurogenesis is critical for cognition (Suh et al., 2009; Christian et al., 2014) and its disruption is associated with cognitive impairment (Aimone et al.”
BackgroundLugert, S., Basak, O., Knuckles, P., Haussler, U., Fabel, K., Götz, M., Haas, C. A., Kempermann, G., Taylor, V., & Giachino, C. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.017 · Cited by 704
Microglia derived from aging mice exhibit an altered inflammatory profile
Sierra, A., Gottfried‐Blackmore, A. C., McEwen, B. S., & Bulloch, K. (2007) · Glia · doi:10.1002/glia.20468 · Cited by 688
Offen, D., Gilgun-Sherki, Y., & Melamed, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0348-9 · Cited by 638 · cited 1×
“Oxidative stress, mitochondrial dysfunction and cytokines, such as TGFbeta are key features of MS pathology (Gilgun-Sherki et al., 2004; Mahad et al., 2009; Haider et al., 2011; Elkjaer et al., 2019).”
BackgroundRegulation and function of adult neurogenesis: from genes to cognition.
Aimone, J. B., Li, Y., Lee, S. W., Clemenson, G. D., Deng, W., & Gage, F. H. (2014) · Physiological Reviews · doi:10.1152/physrev.00004.2014 · Cited by 635 · cited 1×
“, 2014) and its disruption is associated with cognitive impairment (Aimone et al., 2014).”
BackgroundJurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
Astrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 1×
“Senescent astrocytes expressing P16INK4A and secreting metalloproteinase-1 (MMP1) have been found in post-mortem tissues of Alzheimer’s disease patients (Bhat et al., 2012).”
BackgroundDefective cholesterol clearance limits remyelination in the aged central nervous system
Cantuti-Castelvetri, L., Fitzner, D., Bosch-Queralt, M., Weil, M.-T., Su, M., Sen, P., Ruhwedel, T., Mitkovski, M., Trendelenburg, G., Lütjohann, D., et al. (2018) · Science · doi:10.1126/science.aan4183 · Cited by 586 · cited 1×
“Aging has been shown to reduce the capacity for remyelination in several animal models of demyelination (Shen et al., 2008; Hampton et al., 2012; Cantuti-Castelvetri et al., 2018) in which remyelination inefficacy is associated with impaired recruitment of OPCs into demyelinated lesions and slower differentiation into…”
BackgroundImpaired immune surveillance accelerates accumulation of senescent cells and aging
Ovadya, Y., Landsberger, T., Leins, H., Vadai, E., Gal, H., Biran, A., Yosef, R., Sagiv, A., Agrawal, A., Shapira, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07825-3 · Cited by 578
Nait‐Oumesmar, B., Decker, L., Lachapelle, F., Avellana‐Adalid, V., Bachelin, C., & Van Evercooren, A. B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00873.x · Cited by 560 · cited 1×
“In addition, studies have demonstrated that adult NPCs from the subventricular zone (SVZ) and the spinal cord contribute to the generation of new oligodendrocytes and myelin repair in models of demyelination (Nait-Oumesmar et al., 1999; Danilov et al., 2006; Menn et al., 2006; Xing et al., 2014; Maeda et al., 2019).”
BackgroundThe Clinical potential of Senolytic Drugs
Kirkland, J. L., Tchkonia, T., Zhu, Y., Niedernhofer, L. J., & Robbins, P. D. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14969 · Cited by 539 · cited 1×
“Alternatively, senotherapy may be based on the modulation of the senescent cell phenotype (senomorphism) in order to block the damaging effects of the SASP or other senescence-associated mediators (Kirkland et al., 2017).”
BackgroundChinta, S. J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D. T., Campisi, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.092 · Cited by 530
Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics
Petersen, M. A., Ryu, J. K., & Akassoglou, K. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2018.13 · Cited by 527 · cited 1×
“Endothelial senescence leading to a constantly leaky BBB may permit fibrinogen to diffuse into the brain parenchyma and drive axonal damage and loss mediated by persistent microglia activation as well as inhibition of remyelination (Petersen et al., 2018).”
BackgroundReliability of human cortical organoid generation
Yoon, S.-J., Elahi, L. S., Pașca, A. M., Marton, R. M., Gordon, A., Revah, O., Miura, Y., Walczak, E. M., Holdgate, G. M., Fan, H. C., et al. (2019) · Nature Methods · doi:10.1038/s41592-018-0255-0 · Cited by 507 · cited 1×
“Advanced human 3D and organoid culture techniques (Marton et al., 2019; Yoon et al., 2019) could help identify the specific factors that induce CS and the contribution of each cell type to tissue injury.”
BackgroundMitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448 · cited 3×
“We have previously provided evidence of senescent glial cells and neurons showing lipofuscin senescent glial cells in acute and chronic actively demyelinated white matter lesions from SPMS cases using GL13 histochemistry (Kritsilis et al., 2018).”
BackgroundSelf-citationRemyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt, T., Antel, J., König, F. B., Brück, W., & Kuhlmann, T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8260a · Cited by 411 · cited 1×
“This suggests that age-related remyelination failure may contribute to disability progression seen at the advanced stages of MS (Kuhlmann et al., 2008; Goldschmidt et al., 2009).”
BackgroundKotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385
Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures
Marton, R. M., Miura, Y., Sloan, S. A., Li, Q., Revah, O., Levy, R. J., Huguenard, J. R., & Pașca, S. P. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0316-9 · Cited by 362 · cited 1×
“Advanced human 3D and organoid culture techniques (Marton et al., 2019; Yoon et al., 2019) could help identify the specific factors that induce CS and the contribution of each cell type to tissue injury.”
BackgroundConde, J. R., & Streit, W. J. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000202887.22082.63 · Cited by 344
Njie, E. G., Boelen, E., Stassen, F. R., Steinbusch, H. W. M., Borchelt, D. R., & Streit, W. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.008 · Cited by 335 · cited 1×
“Aged microglia exhibit decreased migratory and phagocytic capacity and secrete constitutively greater amounts of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in culture (Njie et al., 2012; Rawji et al., 2020).”
BackgroundSalminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333
Bachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-79 · Cited by 282
Age and disability accumulation in multiple sclerosis
Scalfari, A., Neuhaus, A., Daumer, M., Ebers, G. C., & Muraro, P. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318230a17d · Cited by 279
Tripathi, R. B., Rivers, L. E., Young, K. M., Jamen, F., & Richardson, W. D. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3411-10.2010 · Cited by 277
Xing, Y. L., Röth, P. T., Stratton, J. A. S., Chuang, B. H. A., Danne, J., Ellis, S. L., Ng, S. W., Kilpatrick, T. J., & Merson, T. D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3491-13.2014 · Cited by 275
Evidence That Aging And Amyloid Promote Microglial Cell Senescence
Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D., & Streit, W. J. (2007) · Rejuvenation Research · doi:10.1089/rej.2006.9096 · Cited by 272
Vascular Cell Senescence Contributes to Blood–Brain Barrier Breakdown
Yamazaki, Y., Baker, D. J., Tachibana, M., Liu, C.-C., van Deursen, J. M., Brott, T. G., Bu, G., & Kanekiyo, T. (2016) · Stroke · doi:10.1161/strokeaha.115.010835 · Cited by 263
DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon Stimulation
Moiseeva, O., Mallette, F. A., Mukhopadhyay, U. K., Moores, A., & Ferbeyre, G. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0858 · Cited by 252
Hoenicke, L., & Zender, L. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs124 · Cited by 248 · cited 1×
“Both apoptotic and senescent cells are cleared by the immune system in a highly regulatedmanner andmay contribute to age-related brain volume loss (Hoenicke and Zender, 2012; Ovadya et al., 2018).”
BackgroundCellular senescence: Immunosurveillance and future immunotherapy
Burton, D. G. A., & Stolzing, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.001 · Cited by 221 · cited 1×
“Immune-mediated physiological clearance of senescent cells could potentially be therapeutically enhanced by medications or vaccines aimed at priming the immune response to remove specific senescent populations (Burton and Stolzing, 2018; Song et al., 2020).”
BackgroundChen, H., Ruiz, P. D., McKimpson, W. M., Novikov, L., Kitsis, R. N., & Gamble, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.011 · Cited by 205
Stress-induced senescence in human and rodent astrocytes
Bitto, A., Sell, C., Crowe, E., Lorenzini, A., Malaguti, M., Hrelia, S., & Torres, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.021 · Cited by 204
Associative Learning in Invertebrates
Hawkins, R. D., & Byrne, J. H. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021709 · Cited by 199
Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Song, P., An, J., & Zou, M.-H. (2020) · Cells · doi:10.3390/cells9030671 · Cited by 198
Astrocyte senescence promotes glutamate toxicity in cortical neurons
Limbad, C., Oron, T. R., Alimirah, F., Davalos, A. R., Tracy, T. E., Gan, L., Desprez, P.-Y., & Campisi, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227887 · Cited by 183
Telomere Shortening in Neural Stem Cells Disrupts Neuronal Differentiation and Neuritogenesis
Ferrón, S. R., Marqués-Torrejón, M. Á., Mira, H., Flores, I., Taylor, K., Blasco, M. A., & Fariñas, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3836-09.2009 · Cited by 179
The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS
Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., di Bello, I. C., Pham-Dinh, D., & Levine, J. (2002) · Journal of Neurocytology · doi:10.1023/a:1025747832215 · Cited by 175 · cited 1×
“Adult oligodendrocyte progenitor cells (OPCs) comprising 5–10% of all CNS cells are primarily responsible for carrying out myelin repair following demyelinating events (Reynolds et al., 2002; Tripathi et al., 2010).”
BackgroundSelf-citationCipriani, S., Ferrer, I., Aronica, E., Kovacs, G. G., Verney, C., Nardelli, J., Khung, S., Delezoide, A.-L., Milenkovic, I., Rasika, S., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy096 · Cited by 169 · cited 1×
“Aging is associated with progressive reduction in adult neurogenesis (Lugert et al., 2010; Cipriani et al., 2018), which is ascribed to a diminution of the pool of stem cells capable of activation and division (Lugert et al.”
BackgroundCellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
Rajagopalan, S., & Long, E. O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208248109 · Cited by 168 · cited 1×
“Although CS is a homeostatic response aiming to prevent the proliferation and neoplastic conversion of damaged cells (Munoz-Espin and Serrano, 2014) it also has a role in development (Rajagopalan and Long, 2012; Barbouti et al., 2019).”
BackgroundProgressive telomere shortening occurs in cultured rat microglia, but not astrocytes
Flanary, B. E., & Streit, W. J. (2004) · Glia · doi:10.1002/glia.10301 · Cited by 167
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160 · cited 1×
“vitro and in vivo with promising results (Myrianthopoulos et al., 2019; Thoppil and Riabowol, 2020).”
BackgroundSelf-citationRawji, K. S., Young, A. M. H., Ghosh, T., Michaels, N. J., Mirzaei, R., Kappen, J., Kolehmainen, K. L., Alaeiilkhchi, N., Lozinski, B., Mishra, M. K., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02129-7 · Cited by 153 · cited 1×
“Aged microglia exhibit decreased migratory and phagocytic capacity and secrete constitutively greater amounts of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in culture (Njie et al., 2012; Rawji et al., 2020).”
BackgroundFerrón, S., Mira, H., Franco, S., Cano-Jaimez, M., Bellmunt, E., Ramírez, C., Fariñas, I., & Blasco, M. A. (2004) · Development · doi:10.1242/dev.01215 · Cited by 152 · cited 1×
“Cultured NPCs exhibit characteristics of senescence, such as enlarged and flattened morphology, increased levels of SA-β-Gal and p16 and decreased level of phospho-Retinoblastoma (pRb) upon long term incubation with Aβ oligomers (Ferron et al., 2004; He et al., 2013; Li et al., 2016).”
BackgroundHe, N., Jin, W.-L., Lok, K.-H., Wang, Y., Yin, M., & Wang, Z.-J. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.437 · Cited by 151 · cited 2×
“…activity↑ HMGB1 ROS production Impaired adult neurogenesis in vivo Inhibition of oligodendrocyte differentiation in vitro Ferron et al., 2004, 2019; Bose et al., 2010; He et al., 2013; Yang et al., 2017; Nicaise et al., 2019; Willis et al., 2020 Ependymal cells p16INK4A mRNA ↑ SA-b-Gal activity ↑ ?”
BackgroundKirkwood, T. B. L., Feder, M., Finch, C. E., Franceschi, C., Globerson, A., Klingenberg, C. P., LaMarco, K., Omholt, S., & Westendorp, R. G. J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.008 · Cited by 144
Gene expression profiling of replicative and induced senescence
Purcell, M., Kruger, A., & Tainsky, M. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973327 · Cited by 132
Simvastatin suppresses breast cancer cell proliferation induced by senescent cells
Liu, S., Uppal, H., Demaria, M., Desprez, P.-Y., Campisi, J., & Kapahi, P. (2015) · Scientific Reports · doi:10.1038/srep17895 · Cited by 124 · cited 1×
“This neuroprotective effect may be mediated via its senomorphic actions, which include downregulation of p38MAPK activation, SASP markers, TNFa, and GM-CSF as shown in other settings (Liu et al., 2015; Ayad et al., 2018).”
BackgroundRadiation-induced astrocyte senescence is rescued by Δ133p53
Turnquist, C., Beck, J. A., Horikawa, I., Obiorah, I. E., Von Muhlinen, N., Vojtesek, B., Lane, D. P., Grunseich, C., Chahine, J. J., Ames, H. M., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz001 · Cited by 118
Changes in the Transcriptome of Human Astrocytes Accompanying Oxidative Stress-Induced Senescence
Crowe, E. P., Tuzer, F., Gregory, B. D., Donahue, G., Gosai, S. J., Cohen, J., Leung, Y. Y., Yetkin, E., Nativio, R., Wang, L.-S., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00208 · Cited by 110
Kujuro, Y., Suzuki, N., & Kondo, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911446107 · Cited by 94
Willis, C. M., Nicaise, A. M., Bongarzone, E. R., Givogri, M., Reiter, C. R., Heintz, O., Jellison, E. R., Sutter, P. A., TeHennepe, G., Ananda, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57663-x · Cited by 76
Repeated Lipopolysaccharide Stimulation Induces Cellular Senescence in BV2 Cells
Yu, H.-M., Zhao, Y.-M., Luo, X.-G., Feng, Y., Ren, Y., Shang, H., He, Z.-Y., Luo, X.-M., Chen, S.-D., & Wang, X.-Y. (2012) · Neuroimmunomodulation · doi:10.1159/000330254 · Cited by 76
iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response
Nicaise, A. M., Banda, E., Guzzo, R. M., Russomanno, K., Castro-Borrero, W., Willis, C. M., Johnson, K. M., Lo, A. C., & Crocker, S. J. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.012 · Cited by 64 · cited 1×
“Other progenitor cells including neural progenitor cells (NPCs) and mesenchymal stem cells (MSCs) also have a role in promoting remyelination and tissue repair (Nicaise et al., 2017; Rivera et al., 2019).”
BackgroundAge-related decline in BubR1 impairs adult hippocampal neurogenesis
Yang, Z., Jun, H., Choi, C.-I., Yoo, K. H., Cho, C. H., Hussaini, S. M. Q., Simmons, A. J., Kim, S., van Deursen, J. M., Baker, D. J., et al. (2017) · Aging Cell · doi:10.1111/acel.12594 · Cited by 40 · cited 1×
“This notion is supported by in vivo evidence from the BUBR1 KO progeroid mouse model in which adult neurogenesis was impaired in the SGZ and SVZ in an age-dependent manner (Yang et al., 2017).”
ResultThe progeroid gene BubR1 regulates axon myelination and motor function
Choi, C.-I., Yoo, K. H., Hussaini, S. M. Q., Jeon, B. T., Welby, J., Gan, H., Scarisbrick, I. A., Zhang, Z., Baker, D. J., van Deursen, J. M., et al. (2016) · Aging · doi:10.18632/aging.101032 · Cited by 26
Research works printed but not linked: 71
- Al-Mashhadi, 2015, Oxidative glial cell damage associated with white matter lesions in the aging human brain, Brain Pathol, 25, 565, 10.1111/bpa.12216 · DOI · Paper page
- Ayad, 2018, Regulation of p38 mitogen-activated kinase-mediated fetal membrane senescence by statins, Am. J. Reprod. Immunol., 80, e12999, 10.1111/aji.12999 · DOI
- Barbouti, 2019, In situ evidence of cellular senescence in thymic epithelial cells (TECs) during human thymic involution, Mech. Ageing Dev, 177, 88, 10.1016/j.mad.2018.02.005 · DOI · Paper page
- Berthiaume, 2018, Pericyte structural remodeling in cerebrovascular health and homeostasis, Front. Aging Neurosci, 10, 210, 10.3389/fnagi.2018.00210 · DOI
- Bose, 2010, Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations, Cell Death Dis, 1, e92, 10.1038/cddis.2010.60 · DOI · Paper page
- Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI · Paper page
- Broux, 2015, IL-15 amplifies the pathogenic properties of CD4+CD28− T cells in multiple sclerosis, J. Immunol, 194, 2099, 10.4049/jimmunol.1401547 · DOI
- Broux, 2012, CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients, J. Autoimmun., 38, 10, 10.1016/j.jaut.2011.11.006 · DOI
- Castellazzi, 2020, Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient, Fluids Barriers CNS, 17, 14, 10.1186/s12987-020-0173-2 · DOI
- Chang, 2008, Neurogenesis in the chronic lesions of multiple sclerosis, Brain, 131, 2366, 10.1093/brain/awn157 · DOI
- Chataway, 2014, Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial, Lancet, 383, 2213, 10.1016/S0140-6736(13)62242-4 · DOI · Paper page
- Christian, 2014, Functions and dysfunctions of adult hippocampal neurogenesis, Annu. Rev. Neurosci, 37, 243, 10.1146/annurev-neuro-071013-014134 · DOI · Paper page
- Claes, 2016, Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients, J. Immunol, 197, 4576, 10.4049/jimmunol.1502448 · DOI · Paper page
- Cole, 2020, Accelerated brain ageing and disability in multiple sclerosis, Ann Neurol, 10.1101/584888 · DOI
- Compston, 2008, Multiple sclerosis, Lancet, 372, 1502, 10.1016/S0140-6736(08)61620-7 · DOI · Paper page
- Danilov, 2006, Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis, Eur. J. Neurosci, 23, 394, 10.1111/j.1460-9568.2005.04563.x · DOI · Paper page
- Davalos, 2012, Fibrinogen as a key regulator of inflammation in disease, Semin. Immunopathol, 34, 43, 10.1007/s00281-011-0290-8 · DOI · Paper page
- Davalos, 2012, Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation, Nat. Commun., 3, 1227, 10.1038/ncomms2230 · DOI · Paper page
- De Stefano, 2016, Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 87, 93, 10.1136/jnnp-2014-309903 · DOI · Paper page
- Ding, 2020, Waking up quiescent neural stem cells: molecular mechanisms and implications in neurodevelopmental disorders, PLoS Genet., 16, e1008653, 10.1371/journal.pgen.1008653 · DOI
- Elkjaer, 2019, Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis, Acta Neuropathol. Commun., 7, 205, 10.1186/s40478-019-0855-7 · DOI · Paper page
- Filippi, 2013, Gray matter damage predicts the accumulation of disability 13 years later in MS, Neurology, 81, 1759, 10.1212/01.wnl.0000435551.90824.d0 · DOI · Paper page
- Filippi, 2012, Association between pathological and MRI findings in multiple sclerosis, Lancet Neurol., 11, 349, 10.1016/S1474-4422(12)70003-0 · DOI · Paper page
- Fisniku, 2008, Gray matter atrophy is related to long-term disability in multiple sclerosis: GM atrophy and disability in MS, Ann. Neurol., 64, 247, 10.1002/ana.21423 · DOI · Paper page
- Franklin, 2015, Glia disease and repair- Remyelination, Cold Spring Harb. Perspect. Biol, 7, 1, 10.1101/cshperspect.a020594 · DOI · Paper page
- Görg, 2015, Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy, Glia, 63, 37, 10.1002/glia.22731 · DOI · Paper page
- Habib, 2020, Association between shorter leukocyte telomeres and multiple sclerosis, J. Neuroimmunol., 341, 577187, 10.1016/j.jneuroim.2020.577187 · DOI
- Haider, 2011, Oxidative damage in multiple sclerosis lesions, 134, 1914, 10.1093/brain/awr128 · DOI · Paper page
- Hampton, 2012, Focal immune-mediated white matter demyelination reveals an age associated increase in axonal vulnerability and decreased remyelination efficiency, Am. J. Pathol, 180, 1897, 10.1016/j.ajpath.2012.01.018 · DOI
- Hemmer, 2015, Role of the innate and adaptive immune responses in the course of multiple sclerosis, Lancet Neurol., 14, 406, 10.1016/S1474-4422(14)70305-9 · DOI · Paper page
- Høgestøl, 2019, Cross-sectional and longitudinal MRI brain scans reveal accelerated brain aging in multiple sclerosis, Front. Neurol., 10, 450, 10.3389/fneur.2019.00450 · DOI · Paper page
- Hollands, 2017, Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition, Mol. Neurodegener, 12, 64, 10.1186/s13024-017-0207-7 · DOI · Paper page
- Horiuchi, 2012, Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007 · DOI · Paper page
- Hou, 2018, Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype, Chem. Biol. Interact, 283, 75, 10.1016/j.cbi.2018.02.002 · DOI
- Hou, 2017, Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma, Molecules., 22, 1516, 10.3390/molecules22091516 · DOI · Paper page
- Ikeda, 2010, DNA damage detected with gammaH2AX in endometrioid adenocarcinoma cell lines, Int. J. Oncol., 36, 1081, 10.3892/ijo_00000589 · DOI
- Johansson, 1999, Neural stem cells in the adult human brain, Exp. Cell Res, 253, 733, 10.1006/excr.1999.4678 · DOI · Paper page
- Kirkwood, 2011, On the programmed/non-programmed nature of ageing within the life history, Curr. Biol, 21, R701, 10.1016/j.cub.2011.07.020 · DOI · Paper page
- Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol, 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI · Paper page
- Krysko, 2019, Telomere length is associated with disability progression in multiple sclerosis, Ann. Neurol, 86, 671, 10.1002/ana.25592 · DOI
- Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
- Li, 2016, N-stearoyl-L-tyrosine inhibits the senescence of neural stem/progenitor cells induced by A1-42 via the CB2 receptor, Stem Cells Int., 2016, 7419389, 10.1155/2016/7419389 · DOI
- Lye, 2019, Astrocyte senescence may drive alterations in GFAPα, CDKN2A p14ARF, and TAU3 transcript expression and contribute to cognitive decline, Geroscience, 41, 561, 10.1007/s11357-019-00100-3 · DOI · Paper page
- Maeda, 2019, Potential of adult endogenous neural stem/progenitor cells in the spinal cord to contribute to remyelination in experimental autoimmune encephalomyelitis, Cells, 8, E1025, 10.3390/cells8091025 · DOI
- Mahmoudi, 2019, Turning back time with emerging rejuvenation strategies, Nat. Cell Biol, 21, 32, 10.1038/s41556-018-0206-0 · DOI · Paper page
- Martínez-Cué, 2020, cellular senescence in neurodegenerative diseases, Front. Cell. Neurosci., 14, 16, 10.3389/fncel.2020.00016 · DOI · Paper page
- Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, Elife, 5, e13, 10.7554/eLife.18246.013 · doi:10.7554/elife.18246.013
- Mothe, 2005, Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat, Neuroscience, 131, 177, 10.1016/j.neuroscience.2004.10.011 · DOI · Paper page
- Nakamura, 2008, Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence, Epigenet. Chromatin, 1, 6, 10.1186/1756-8935-1-6 · DOI · Paper page
- Neumann, 2019, Metformin restores CNS remyelination capacity by rejuvenating aged stem cells, Cell. Stem Cell. 25, 473, 10.1016/j.stem.2019.08.015 · DOI · Paper page
- Nicaise, 2019, Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis, Proc. Natl. Acad. Sci. U.S.A, 116, 9030, 10.1073/pnas.1818348116 · DOI · Paper page
- Nie, 2015, 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces premature senescence of astrocytes via WNT/-catenin signaling and ROS production, J. Appl. Toxicol, 35, 851, 10.1002/jat.3084 · DOI · Paper page
- Oost, 2018, Targeting senescence to delay progression of multiple sclerosis, J. Mol. Med. (Berl)., 96, 1153, 10.1007/s00109-018-1686-x · DOI
- Papadopoulos, 2006, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Exp. Neurol, 197, 373, 10.1016/j.expneurol.2005.10.033 · DOI · Paper page
- Pardo, 2017, The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations, J. Neurol, 264, 2351, 10.1007/s00415-017-8594-9 · DOI
- Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol. Appl. Neurobiol., 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI · Paper page
- Pertusa, 2007, Astrocytes aged in vitro show a decreased neuroprotective capacity, J. Neurochem, 101, 794, 10.1111/j.1471-4159.2006.04369.x · DOI · Paper page
- Poulsen, 2014, Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence, Ann. Rheum. Dis, 73, 1405, 10.1136/annrheumdis-2012-203146 · DOI · Paper page
- Prozorovski, 2019, Regulation of sirtuin expression in autoimmune neuroinflammation: induction of SIRT1 in oligodendrocyte progenitor cells, Neurosci. Lett, 704, 116, 10.1016/j.neulet.2019.04.007 · DOI
- Rivera, 2019, Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination, Glia, 67, 1510, 10.1002/glia.23624 · DOI
- Shen, 2008, Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency, Nat. Neurosci, 11, 1024, 10.1038/nn.2172 · DOI · Paper page
- Sim, 2002, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J. Neurosci., 22, 2451, 10.1523/JNEUROSCI.22-07-02451.2002 · DOI · Paper page
- Suh, 2009, Signaling in adult neurogenesis, Annu. Rev. Cell Dev. Biol, 25, 253, 10.1146/annurev.cellbio.042308.113256 · DOI · Paper page
- Tamanini, 2018, In vivo transient and partial cell reprogramming to pluripotency as a therapeutic tool for neurodegenerative diseases, Mol. Neurobiol., 55, 6850, 10.1007/s12035-018-0888-0 · DOI
- Thewissen, 2005, Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients, Ann. N. Y. Acad. Sci, 1051, 255, 10.1196/annals.1361.066 · DOI · Paper page
- Thoppil, 2020, Senolytics: a translational bridge between cellular senescence and organismal aging, Front. Cell. Dev. Biol., 7, 367, 10.3389/fcell.2019.00367 · DOI
- Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 · DOI · Paper page
- Weiss, 1996, Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis, J. Neurosci, 16, 7599, 10.1523/JNEUROSCI.16-23-07599.1996 · DOI · Paper page
- Weissert, 2013, The immune pathogenesis of multiple sclerosis, J. Neuroimmune Pharmacol, 8, 857, 10.1007/s11481-013-9467-3 · DOI
- Werner, 2001, Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage, Ann. Neurol., 50, 169, 10.1002/ana.1077 · DOI · Paper page
- Yabluchanskiy, 2020, Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation–induced impairment of neurovascular coupling responses protecting cognitive function in mice, Geroscience, 42, 409, 10.1007/s11357-020-00154-8 · DOI
Cited by
Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology
Zou, P., Wu, C., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00385-7 · Cited by 97
“These substances have the potential to impact neighboring cells, triggering their senescence and initiating a vicious cycle that accelerates the aging process [173].”
BackgroundSenescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84
Cellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Metadata
- Authors
- Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-06-30
- Volume
- 14
- Pages
- 178-178
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W3039523091
- Cited by
- 79
- References
- 79
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.